Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 26, 1997, Pages 14854-14858

  Jenck, Francois ^a   Moreau, Jean Luc ^a   Martin, James R ^a   Kilpatrick, Gavin J ^a   Reinscheid, Rainer K ^b   Monsma Jr , Frederick J ^c   Nothacker, Hans Peter ^d   Civelli, Olivier ^d  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Benzodiazepine; Neuropeptite; Operant conflict; Plus maze

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; NEUROPEPTIDE; NOCICEPTIN; OPIATE RECEPTOR;

AMINO ACID ANALYSIS; AMINO ACID COMPOSITION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; FEEDING; INSTRUMENTAL CONDITIONING; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SENSORIMOTOR FUNCTION; STRESS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; MALE; MICE; MICE, INBRED BALB C; OPIOID PEPTIDES; RECEPTORS, OPIOID; STRESS;

EID: 0031463956     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.26.14854     Document Type: Article

References (35)

1. Reinscheid, R. K., Nothacker, H. P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., Jr., & Civelli, O. (1995) Science 270, 792-794.
2. Meunier, J. C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J. L., Guillemot, J. C., Ferrara, P., Monsarrat, B., Mazarguil, H., Vassart, G., Parmentier, M. & Costentin, J. (1995) Nature (London) 377, 532-535.
3. Bunzow, J. R., Saez, C., Mortrud, M., Bouvier, C., Williams J. T., Low, M. & Grandy, D. K. (1994) FEBS Lett. 347, 284-288.
4. Chen, Y., Fan, Y., Liu, J., Mestek, A., Tian, M., Kozak, C. A. & Yu, L. (1994) FEBS Lett. 347, 279-283.
5. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J. L., Moisand, C., Chalon, P., Caput, D., Vassart, G. & Meunier, J. C. (1994) FEBS Lett. 341, 33-38.
6. Wang, J. B., Johnson, P. S., Imai, Y., Persico, A. M., Ozenberger, B. A., Eppler, C. M. & Uhl, G. R. (1994) FEBS Lett. 348, 75-79.
7. Wick, M. J., Minnerath, S. R., Lin, X., Elde, R., Law, P. Y. & Loh, H. H. (1994) Mol. Brain Res. 27, 37-44.
8. Lachowicz, J. E., Shen, Y., Monsma, F. G., Jr., & Sihley, D. R. (1995) J. Neurochem. 64, 34-40.
9. Matthes, H., Seward, E. P., Kieffer, B. & North, R. A. (1996) Mol. Pharmacol. 50, 447-450.
10. Knoflach, F., Reinschcid, R. K., Civelli, O. & Kemp, J. A. (1996) J. Neurosci. 16, 6657-6664.
11. Reinscheid, R. K., Ardati, A., Monsma, F. J., Jr., & Civelli, O. (1996) J. Biol. Chem. 271, 14163-14168.
12. Mogil, J. S., Grisel, J. E., Zhangs, G., Belknap, J. K. & Grandy, D. K. (1996) Neurosci. Lett. 214, 131-134.
13. Mogil, J. S., Grisel, J. E., Reinscheid, R. K., Civelli, O., Belknap, J. K. & Grandy, D. K. (1996) Neuroscience 75, 333-337.
14. Pomonis, J. D., Billington, C. J. & Levine, A. S. (1996) NeuroReport 8, 369-371.
15. Florin, S., Suaudeau, C., Meunier, J. C. & Costentin, J. (1996) Eur. J. Pharmacol. 317, 9-13.
16. Rossi, G. C., Leventhal, L. & Pasternak, G. W. (1996) Eur. J. Pharmacol. 311, R7-R8.
17. Xu, X. J, Hao, J. X. & Wiesenfeld-Hallin, Z. (1996) NeuroReport 7, 2092-2094.
18. Fukuda, K., Kato, S., Mori, K., Nishi, M., Takeshima, H., Iwabe, N., Miyata, T., Houtani, T. & Sugimoto, T. (1994) FEBS Lett. 343, 42-46.
19. Nothacker, H. P., Reinscheid, R., Mansour, A., Henningsen, R. A., Ardati, A., Monsma, F. J., Jr., Watson, S. J. & Civelli, O. (1996) Proc. Natl. Acad. Sci. USA 93, 8677-8682.
20. Crawley, J. & Goodwin, F. K. (1980) Pharmacol. Biochem. Behav. 13, 167-170.
21. Beizung, C., Misslin, R., Vogel, E., Dodd, R. H. & Chapoutier, G. (1987) Pharmacol. Biochem. Behav. 29, 29-33.
22. Pellow, S., Chopin, P., File, S. E. & Briley, M. (1985) J. Neurosci. Methods 14, 149-167.
23. Russell, P. A. (1973) Br. J. Psychol. 64, 417-433.
24. Gray, J. A. (1982) The Neuropsychology of Anxiety (Oxford Univ. Press, New York).
25. Lister, R. (1990) Pharmacol. Ther. 46, 320-341.
26. Moreau, J. L., Kilpatrick, G. J. & Jenck, F. (1997) NeuroReport 8, 1697-1701.
27. Geller, I. & Seifter, J. (1960) Psychopharmacologia 1, 482-492.
28. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., Rivier, J., Sawchenko, J. & Vale W. (1995) Nature (London) 378, 287-292.
29. Spina, M., Merlo-Pich, E., Chan, R. K. W., Basso, A. M., Rivier, J., Vale, W. & Koob, G. F. (1996) Science 273, 1561-1564.
30. Devine, D. P., Reinscheid, R., Monsma, F. J., Jr., Civelli, O. & Akil, H. (1996) Brain Res. 727, 225-229.
31. Murphy, N. P., Ly, H. T. & Maidment, N. T. (1996) Neuroscience 75, 1-4.
32. Herman, J. P. & Culliman, W. E. (1997) Trends Neurosci. 20, 78-84.
33. Heilig, M., Koob, G. F., Ekman, R. & Britton, K. T. (1994) Trends Neurosci. 17, 80-85.
34. Broqua, P., Wettstein, J. G., Rocher, M. N., Gauthier-Martin, B. & Junien, J. L. (1995) Behav. Pharmacol. 6, 215-22.
35. Harro, J., Vasar, E. & Bradwejn, J. (1993) Trends Pharmacol. Sci. 14, 244-249.